Zimbra Community Charts Email and Collaboration Advancements That Drive Adoption
Synacor Inc. (NASDAQ: SYNC) today announced that Zimbra Forum France attracted more than 200 participants from the platform’s international community of channel partners, developers, and customers in Paris, France. At the ninth annual event, attendees discussed key features for the Zimbra development roadmap, participated in deep dives on the recently launched Zimbra 8.8 collaboration platform, and shared innovative ideas from across the community that drive customer adoption of Zimbra.
During the event, the Zimbra community identified key features driving the future of collaboration across email, calendaring, chat and more. Recurring themes included solutions that are cloud-friendly, feature modern and easily customizable user interfaces, and automatically address user traffic.
"We see growing interest from enterprise users for alternatives to their existing groupware solution,” said Hans-Joerg Happel, CTO and Co-Founder of audriga. “With planned features, Zimbra is well-positioned to address market needs and Zimbra Forum France was a good opportunity to discuss how we can help more customers make a switch to Zimbra."
“Zimbra Forum France was compelling and helpful. Zimbra showed its 2018 roadmap including the upcoming release, Zimbra 8.8, patches, Zimbra Talk v2 and Drive 2,” said Stefano Pampaloni, CEO at Seacom. “We’re pleased that Zimbra is focused on meeting partner needs and understanding the differences of each market we serve with an open and customer-focused approach.”
Giuliano Ippoliti, Director of Agency at Cloud Temple, a fast growing IT service provider from France, highlighted the important role of providing an enjoyable and engaging email experience, even for enterprise customers, “Enterprise customers have grown accustomed to visual consumer features and other engaging third-party services incorporated into their collaboration products. The next generation of enterprise email needs to include these same features.”
Now in its ninth year, Zimbra Forum France followed the commercial launch of Zimbra 8.8, which debuted new user experience features such as Zimbra Drive for enterprise-level file sync and sharing, and Zimbra Chat. The Network Edition features tech stack enhancements including real-time backup, ActiveSync across mobile and desktop, hierarchical storage management that enables customers to move archival data to less expensive storage solutions, and improved delegated admin functionality.
“This gathering of our community’s developers, specialists and power users is critical to Zimbra’s continued advancement,” said Marcus Teo, Senior Vice President, Enterprise Sales and Marketing at Synacor. “We extend a sincere thank you to the 200 attendees who came to learn, share and innovate, and are committed to supporting the continued evolution of the world’s best open source collaboration platform based on the key takeaways emerging from the event.”
Sponsors and partners supporting Zimbra Forum France included Audriga, Beezim, Cloud Temple, Commeo, ilger.com, MxSolutions, Red Hat, Seacom, StarXpert, TechData, VadeSecure and Zextras. Zimbra Forum France is targeted at the European community, while other Zimbra conferences include the Zimbra APxJ Partner Summit.
About Zimbra Email and Collaboration
Zimbra, a Synacor product, connects people and information with unified collaboration software that includes email, calendaring, file sharing, chat and video chat. It powers approximately 500 million mailboxes and works with more than 1,900 channel partners. Enterprises, governments and service providers trust Zimbra.
Zimbra can be deployed on-premises, in the cloud or as a hybrid service. The Zimbra Business Solution Provider Network offers it as a Hosted Service. Synacor operates a turnkey, fully hosted/managed, and monetized solution for Service Providers.
Synacor (Nasdaq:SYNC) is the trusted technology development, multiplatform services and revenue partner for video, Internet and communications providers, device manufacturers, governments and enterprises. Synacor’s mission is to enable its customers to better engage with their consumers. Its customers use Synacor’s technology platforms and services to scale their businesses and extend their subscriber relationships. Synacor delivers managed portals, advertising solutions, email and collaboration platforms, and cloud-based identity management. www.synacor.com
For more information about becoming a Zimbra Partner visit https://www.zimbra.com/partners/become-partner/
Matt Wolfrom, 716-362-3880
VP, Corporate Communications
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues26.3.2019 06:00:00 CET | Pressemelding
Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens. One of the first projects of its kind worldwide, the endeavor aims to acquire new knowledge in terms of the medical and biological understanding of special factors underlying the development of human neuropsychiatric diseases through the ages. Ultimately, the project may provide a new approach to the development of medicines and other therapeutic treatments for mental and neurological conditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190325005867/en/ Where do brain disorders come from? In an effort to shed light on the role of microbes in the pathogenesis of neuropsychiatric illnesses, such as Alzheimer’s disease and schizophrenia, Professor Eske Willerslev and his team
Earth Networks Announces Completion of Severe Weather Early Warning System for PAGASA25.3.2019 23:00:00 CET | Pressemelding
Earth Networks announced today the completion of the Philippines’ first nationwide severe weather monitoring and alerting network with associated software services for the Philippine Atmospheric, Geophysical, and Astronomical Services Administration (PAGASA), the National Meteorological and Hydrological Services (NMHS) agency of the Republic of the Philippines. The announcement was made at the 6th annual InterMET Asia conference in Singapore. Initiated in 2017, and formally commissioned this week, the technology partnership between PAGASA and Earth Networks is the first of its kind in the Philippines and surrounding regions, powered by a network of total lightning sensors and real-time automatic weather stations for mesoscale monitoring. Installed and operated together with Philippines partner West Point Engineering, the 10-year program includes: Real-time lightning detection powered by the Earth Networks Total Lightning Network On-the-ground weather monitoring via the Earth Networks W
Game of Thrones Winter is Coming™ Launches Worldwide25.3.2019 23:00:00 CET | Pressemelding
Yoozoo Games, a leading game developer and publisher, today announced the global launch of Game of Thrones Winter is Coming™ , a real-time strategy PC browser game officially licensed by Warner Bros. Interactive Entertainment under license from HBO®. The game is now available in English, with additional languages to follow. HBO, Warner Bros. Interactive Entertainment and Yoozoo Games have collaborated to recreate Westeros on a massive scale, delivering an authentic and immersive multiplayer world laid out across the Seven Kingdoms – complete with major landmarks and castles from the epic TV series. The story begins immediately following the death of Eddard Stark, when the player emerges as a new Westeros lord or lady in his stead. Strategising starts in earnest in Game of Thrones Winter is Coming as players aim to build an impenetrable base, train a victorious army and recruit faithful followers from a pool of iconic characters. As players progress, they must continue to acquire the mi
bluebird bio Statement on European Regulatory Status of LentiGlobin™25.3.2019 22:40:00 CET | Pressemelding
A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin™, bluebird bio’s investigational gene therapy for the treatment of transfusion dependent β-thalassemia (TDT). LentiGlobin for TDT is scheduled to be reviewed as part of the CHMP (Committee on Human Medicinal Products) meeting from March 25 – 28, however no opinion has been issued by the CHMP. If the CHMP’s opinion is issued it would then be reviewed by the European Commission (EC), which has the authority to grant approval for the use of LentiGlobin in the EU. About bluebird bio, Inc. bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working
Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis25.3.2019 20:30:00 CET | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5). The pivotal efficacy and safety data provided in the application result from the SUNBEAM™ and RADIANCE™ Part B phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trials. “New oral treatment options with differentiated profiles like ozanimod are needed to help address an unmet need for people with relapsing forms of MS,” said Jay Backstrom, M.D., Chief Medical Officer for Celgene. “With concurrent applications in the U.S. and EU, we look forward to advancing this promising medicine through the regulatory review process to provide a new option for the treatment of RMS in
AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia25.3.2019 19:50:00 CET | Pressemelding
Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β0/β0 genotype. As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency. Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available. “People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, includin